In 2023, the average length of stay for glomerular and renal tubulo-interstitial diseases in the UK was slightly above 4.4 days. Forecasts indicate a gradual decline from 4.4 days in 2024 to 4.1 days by 2028. The year-on-year variation shows a slight decrease, approximately 2.3%, reflecting improvements in medical protocols and treatment efficiency. Over the forecasted five-year period, the compound annual growth rate (CAGR) indicates an average annual reduction of about 1.7% in hospital stays.
Future trends to watch include the adoption of advanced medical technologies, personalized treatments, and enhanced outpatient services that could further reduce hospital stay durations, thereby optimizing resource utilization in healthcare facilities.
